SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001181431-13-017026
Filing Date
2013-03-14
Accepted
2013-03-14 18:02:10
Documents
1
Period of Report
2013-03-11

Document Format Files

Seq Description Document Type Size
1 FORM 4/A rrd374145.html 4/A  
1 FORM 4/A rrd374145.xml 4/A 20194
  Complete submission text file 0001181431-13-017026.txt   21722
Mailing Address 3900 PARAMOUNT PARKWAY SUITE 150 MORRISVILLE NC 27560
Business Address 3900 PARAMOUNT PARKWAY SUITE 150 MORRISVILLE NC 27560 919-456-7800
Furiex Pharmaceuticals, Inc. (Issuer) CIK: 0001484478 (see all company filings)

IRS No.: 271197863 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O FURIEX PHARMACEUTICALS, INC. 3900 PARAMOUNT PARKWAY, SUITE 150 MORRISVILLE NC 27560
Business Address
Kaldor Stephen W (Reporting) CIK: 0001507502 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-34641 | Film No.: 13691570